Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 76744 | NSE Symbol : ARISTO | ISIN : INE082101010 | Industry : Pesticides / Agrochemicals - Indian |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
10-Mar-2025	10-Mar-2025	Change in Auditors	Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on March 10, 2025.
08-Nov-2024	14-Nov-2024	Half Yearly Results	To consider and approve the financial results for the period ended September 30, 2024 and other business matters ARISTO : 14-Nov-2024 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 14, 2024, To consider and approve the financial results for the period ended September 30, 2024 and other business matters (As Per NSE Announcement Dated on: 13/11/2024) Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on November 14, 2024. (As Per NSE Announcement Dated on: 14/11/2024)
28-Aug-2024	28-Aug-2024	AGM	Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on August 28, 2024.
21-May-2024	27-May-2024	Quarterly Results	To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on May 27, 2024. (As Per NSE Announcement Dated on: 27/05/2024)
31-Oct-2023	07-Nov-2023	Half Yearly Results	Intimation of Board meeting for consideration of Unaudited Financial Results of the Company for the Half year ended on September 30, 2023. Outcome of Board Meeting held today i.e. on November 07, 2023 in terms of second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.Ref: Aristo Bio-Tech and Lifescience Limited (Symbol: - ARISTO, ISIN: - INE082101010)In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held today, i.e. on Tuesday, November 07, 2023, at the Registered Office of the Company situated at at E-24,25,26, G.I.D.C. Manjusar, Ta. Savli, Vadodara-391775, Gujarat, India which was commenced at 5:00 P.M. and concluded at 5:45 P.M., to have:1. Considered, approved and taken on record the Unaudited financial result of the Company for the Half year ended on September 30, 2023, and2. Statement of Assets and Liabilities.3. Cash Flow Statement.4. Approved the Limited Review Report issued by Statutory Auditors of the Company for the Half year ended on September 30, 2023,5. Took Note of the Resignation of Mr. Dipakkumar Harkant Joshi (DIN: 08549339), Non-Executive Director of the company due to personal reasons and personal commitment, with effect from close of business hours of November 07, 2023.6. Appointed M/s. SCS AND CO. LLP, Practicing Company Secretary, Ahmedabad as Secretarial Auditor for Secretarial Audit of the Company for the F.Y. 2023-247. Considered and approved all other business as per agenda circulated.Further, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the Unaudited Financial Results for the Half year ended September 30, 2023 and Limited Review Report issued by Statutory Auditors on the Unaudited Financial results for the half year ended September 30, 2023.Resignation Letter received from Mr. Dipakkumar Harkant Joshi (DIN: 08549339) is enclosed herewith. Brief Profile of SCS AND CO. LLP, Practicing Company Secretary are also enclosed herewithFurther, Details as required under regulation 30 of listing regulations read with SEBI circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are provided herewith. (As Per NSE Announcement Dated on: 07/11/2023) Aristo Bio Tech And Lifescience Limited has informed the Exchange regarding Resignation of Mr Dipakkumar Harkant Joshi as Non- Executive Director of the company w.e.f. November 08, 2023. Aristo Bio Tech And Lifescience Limited has informed the Exchange regarding Appointment of Ms SCS AND CO LLP as Secretarial auditor of the company w.e.f. April 01, 2023. (As Per NSE Announcement Dated on: 08/11/2023)
28-Aug-2023	28-Aug-2023	Accounts	Aristo Bio Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on August 28, 2023.
20-Jun-2023	20-Jun-2023	Change in Auditors	Aristo Bio Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on Jun 20, 2023.
20-May-2023	27-May-2023	Accounts	has informed the Exchange about Board Meeting to be held on 27 May 2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Other business. ARISTO BIO TECH AND LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend.
06-Feb-2023	06-Feb-2023	Quarterly Results	Aristo Bio Tech And Lifescience Limited has informed the Exchange regarding Board meeting held on February 06, 2023. With reference to the above captioned subject, and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the company in their meeting held today i.e. on Monday, February 06, 2023 at the registered office of the Company situated at E-24,25,26, G.I.D.C., Ta. Savli, Manjusar, Vadodara-391775, Gujarat which was commenced at 04:30 P.M. and concluded at 05:30 P.M., have considered and approved the following:1. Appointed M/s. SCS and Co. LLP, Practicing Company Secretary, Ahmedabad as Secretarial Auditor for Secretarial Audit of the Company for the F.Y. 2022-23.2. Authorised various Key Managerial Personnel for the purpose of determining the Materiality of events or information for the purpose of making disclosure to the Stock Exchange.3. Considered and approved all other business as per agenda circulated. Aristo Bio Tech And Lifescience Limited has informed the Exchange regarding 'Intimation of Contact Details of Key Managerial personnel, pursuant to Regulation 30(5) of the SEBI (Listing Regulations and Disclosure Requirements) Regulations, 2015. Ref: Aristo Bio-Tech and Lifescience Limited (Symbol: - ARISTO, ISIN: - INE082101010)Pursuant to captioned subject, we are pleased to inform you that the board of Directors of the Company has, vide its resolution passed pursuant to regulation 30(5) of the SEBI (Listing Obligation and Disclosure Requirement Regulations) 2015, in the Board meeting held today i.e. on Monday, February 06, 2023, has authorised below mentioned Key Managerial Personnel for the purpose of determining the Materiality of events or information for the purpose of making disclosure to the Stock Exchange:Sr. No. Name of Personnel Designation Contact Details1 Narendra Singh Barhat Chairman & Managing Director Email cs@aristobiotech.com/mail@aristobiotech.comPh. No.: +91-9991118015/+91-96875449992 Ketankumar Harkantbhai Joshi Whole Time Director & CFO 3 Company Secretary & Compliance officer The aforesaid details are also uploaded on our Website of the Company i.e. http://www.aristobiotech.com/. '.

LOGIN HERE

Aristo Bio-Tech & Lifescience Ltd

Board Meeting